FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study identifies new target for obesity-related breast cancer

2.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

3.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

4.

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

5.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot